Emergency Guidance Clears Way For COVID-19 Blood Clot Detection Devices
Executive Summary
The US FDA is waiving premarket notification requirements for coagulation systems to monitor COVID-19 patients who are at high risk for blood clotting.
You may also be interested in...
FDA Updates Labeling Requirement In Emergency Blood Clot Detection Device Guidance
The US agency added a minor update to the original guidance that broadens the labeling requirement for the devices to state they are only to be used as adjunctive diagnostics when evaluating a COVID-19 patient for risk of blood clots.
FDA Suspends Premarket Notification Requirement For 7 Devices; 84 More Under Consideration
The US HHS and the FDA on 14 January published a notice that permanently waives premarket notification requirements for seven types of gloves that were given temporary waiver during the pandemic. Regulators are looking to expand the waiver to 84 other products.
Massive Family Dollar Rat Infestation Leads To Multi-State Recall
The US FDA found more than 2,000 rats at an Arkansas Family Dollar distribution center, leadingto a six-state recall for products including feminine hygiene products, contact lens cleaners and face masks.